Literature DB >> 16259732

Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction.

Hiroshi Ozaki1, Masatoshi Hori, Kazuya Kinoshita, Takashi Ohama.   

Abstract

Inflammation suppresses intestinal motility, which secondarily induces abnormal growth of intestinal flora. Disturbance of this flora plays a role in the pathogenesis of mucosal inflammation, which in turn aggravates the intestinal dysmotility. Therefore, it is important to know the mechanism of alteration in motor function in the inflamed intestine. Recent studies have shown molecular mechanisms responsible for the motility disorder in the inflamed gut. These include an increase in the activity of myosin light-chain phosphatase and an alteration of ion channel activity in smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259732     DOI: 10.1163/156856005774423773

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  48 in total

Review 1.  Regulation of smooth muscle contractile elements by second messengers.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

Review 2.  Invited review: regulation of myosin phosphorylation in smooth muscle.

Authors:  G Pfitzer
Journal:  J Appl Physiol (1985)       Date:  2001-07

3.  Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines.

Authors:  Matthew D Vrees; Victor E Pricolo; Fabio M Potenti; Weibiao Cao
Journal:  Arch Surg       Date:  2002-04

4.  How to express pharmacological contractions of the inflamed rat intestine.

Authors:  T G Moreels; J G De Man; B Y De Winter; A G Herman; P A Pelckmans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-12       Impact factor: 3.000

5.  Gastrointestinal motility in patients with ulcerative colitis.

Authors:  S S Rao; N W Read
Journal:  Scand J Gastroenterol Suppl       Date:  1990

6.  Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis.

Authors:  T R Koch; J A Carney; V L Go; J H Szurszewski
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

7.  Protein and gene expression of Ca2+ channel isoforms in murine colon: effect of inflammation.

Authors:  Minho Kang; Nemat Morsy; Xiaochun Jin; Florea Lupu; Hamid I Akbarali
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

8.  Isolation and characterization of resident macrophages from the smooth muscle layers of murine small intestine.

Authors:  H Ozaki; T Kawai; C W Shuttleworth; K-J Won; T Suzuki; K Sato; H Horiguchi; M Hori; H Karaki; S Torihashi; S M Ward; K M Sanders
Journal:  Neurogastroenterol Motil       Date:  2004-02       Impact factor: 3.598

9.  Altered gene expression and increased bursting activity of colonic smooth muscle ATP-sensitive K+ channels in experimental colitis.

Authors:  Xiaochun Jin; Anna P Malykhina; Florea Lupu; Hamid I Akbarali
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02-12       Impact factor: 4.052

10.  Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscle.

Authors:  Toshio Kitazawa; Masumi Eto; Terence P Woodsome; Md Khalequzzaman
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

View more
  11 in total

1.  Azathioprine in the management of enteropathy in cystic fibrosis.

Authors:  Hui-Leng Tan; Neil Shah; Ranjan Suri
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 2.  Microscopic colitis in older adults: impact, diagnosis, and management.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ther Adv Chronic Dis       Date:  2022-07-05       Impact factor: 4.970

3.  Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1beta.

Authors:  Wenhui Hu; Sunila Mahavadi; Fang Li; Karnam S Murthy
Journal:  Am J Physiol Cell Physiol       Date:  2007-10-24       Impact factor: 4.249

4.  Mycobacterium avium subspecies paratuberculosis infects and multiplies in enteric glial cells.

Authors:  Leonardo A Sechi; Anne Ruehl; Niyaz Ahmed; Donatella Usai; Daniela Paccagnini; Giovanna E Felis; Stefania Zanetti
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

5.  Effect of Agonist and Antagonist on the In Vitro Contractility of Inflamed Vermiform Appendix.

Authors:  Phani Bhushan Singh; Pushpakant Tiwary; Sanjeev K Singh; Ratna Pandey; Atanu Roy; Amrita Ghosh Kar; Somprakas Basu; Anil Kumar Tiwari
Journal:  J Clin Diagn Res       Date:  2017-06-01

6.  Receptor tyrosine and MAP kinase are involved in effects of H(2)O(2) on interstitial cells of Cajal in murine intestine.

Authors:  Seok Choi; Cheol Ho Yeum; Young Dae Kim; Chan Guk Park; Man Yoo Kim; Jong-Seong Park; Han-Seong Jeong; Byung Joo Kim; Insuk So; Ki Whan Kim
Journal:  J Cell Mol Med       Date:  2010-01       Impact factor: 5.310

Review 7.  Opportunities to Target Specific Contractile Abnormalities with Smooth Muscle Protein Kinase Inhibitors.

Authors:  Annegret Ulke-Lemée; Justin A MacDonald
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-26

8.  Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent rats.

Authors:  Changchun Yu; Yongjian Xiong; Dapeng Chen; Yanli Li; Bin Xu; Yuan Lin; Zeyao Tang; Chunling Jiang; Li Wang
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

9.  Protective effects of curcumin against rat intestinal inflammation‑related motility disorders.

Authors:  Yang Yao; Ranyuan Luo; Shu Xiong; Chang Zhang; Yukun Zhang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

10.  Microscopic colitis: controversies in clinical symptoms and autoimmune comorbidities.

Authors:  Istvan Fedor; Eva Zold; Zsolt Barta
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.